Dr. Ana Beatriz DePaula-Silva received her B.Sc. from the Sao Paulo State University and a Ph.D. from the University of Utah. She is an Assistant Professor of Pharmacology and Toxicology at the University of Utah. Dr. DePaula-Silva’s lab is focused on understanding how virus–host interactions are associated with the development of neuroinflammatory and neurodegenerative diseases, focusing mechanistically on the involvement of CNS-infiltrating immune cells in the development of epilepsy and multiple sclerosis. She was named a recipient of the Cure Epilepsy Taking Flight Award for her proposed work to study the effect of gut microbiota and derived metabolites on the development of epilepsy following a CNS viral infection. She received the prestigious NIH-NINDS K22 Career Transition Award to study the role of brain infiltrating macrophages on neuroinflammation and seizures.
Dr. Ana Beatriz DePaula-Silva received her B.Sc. from the Sao Paulo State University and a Ph.D. from the University of Utah. She is an Assistant Professor of Pharmacology and Toxicology at the University of Utah. Dr. DePaula-Silva’s lab is focused on understanding how virus–host interactions are associated with the development of neuroinflammatory and neurodegenerative diseases, focusing mechanistically on the involvement of CNS-infiltrating immune cells in the development of epilepsy and multiple sclerosis. She was named a recipient of the Cure Epilepsy Taking Flight Award for her proposed work to study the effect of gut microbiota and derived metabolites on the development of epilepsy following a CNS viral infection. She received the prestigious NIH-NINDS K22 Career Transition Award to study the role of brain infiltrating macrophages on neuroinflammation and seizures.